BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34625711)

  • 1. A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Zhang J; Zhai J; Wong CC; Chen H; Wang X; Ji J; Yu J
    Oncogene; 2021 Dec; 40(49):6641-6652. PubMed ID: 34625711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
    Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
    J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
    Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
    Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
    Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
    Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
    Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
    Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine demethylase 5B suppresses CC chemokine ligand 14 to promote progression of colorectal cancer through the Wnt/β-catenin pathway.
    Yan G; Li S; Yue M; Li C; Kang Z
    Life Sci; 2021 Jan; 264():118726. PubMed ID: 33160990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
    Yan X; Huang L; Liu L; Qin H; Song Z
    Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
    Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
    J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
    Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
    Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
    Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
    Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
    Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
    Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.